Pharmaceuticals, Biotechnology and Life Sciences
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA™ (NYSE: IQV), a leader in Human Data Science, today announced its new…
Second-quarter revenue $2,740 million Adjusted EBITDA $578 million GAAP Diluted Earnings per Share $0.30; Adjusted Diluted Earnings per Share $1.53…
Indian Glenmark Pharmaceuticals has been granted final approval by the U.S. FDA for Ezetimibe and Simvastatin Tablets, for several doses.
Disruptive tech simplifies patient engagement and amplifies patients’ voices to advance outcomes for life science companies DANBURY, Conn. & RESEARCH…
IQVIA Institute for Human Data Science Study: Record 59 New U.S. Drugs Launched in 2018, Success Rates Fall, R&D Trends Could Improve Productivity by 2023
Dr.Reddy’s has entered into a definitive agreement toacquire a portfolio of 42 approved, non-marketed Abbreviated New DrugApplications (ANDAs) in the U.S.